# HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

> **NCT05962242** · PHASE2 · RECRUITING · sponsor: **University of Virginia** · enrollment: 90 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of the Oropharynx

## Interventions

- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT05962242
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-28
- **Primary completion:** 2027-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962242, "HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05962242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*